Buprenorphine transdermal skin patch and Sandostatin LAR
Determining the interaction of Buprenorphine transdermal skin patch and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Sandostatin LAR Depot
- Buprenorphine transdermal skin patch-Sandostatin LAR Depot injection
- Buprenorphine transdermal skin patch-Sani-Supp
- Buprenorphine transdermal skin patch-Sani-Supp rectal
- Buprenorphine transdermal skin patch-Sansert
- Buprenorphine transdermal skin patch-Santyl
- Sandostatin LAR-Buprenorphine, Buprenorphine Hydrochloride
- Sandostatin LAR-Buprenorphine/naloxone Oromucosal, Sublingual
- Sandostatin LAR-Buproban
- Sandostatin LAR-Bupropion
- Sandostatin LAR-Bupropion and naltrexone
- Sandostatin LAR-Bupropion Extended-Release Tablets